Plan the Proof, Accelerate Access with Integrated Evidence Planning  

Integrated Evidence Plan – Frequently Asked Questions

• What’s the purpose of an Integrated Evidence Plan (IEP)?

   To create a single, cross‑functional roadmap that tells you which studies to run, in what order, for which stakeholders—so every dollar of evidence spend moves you closer to regulatory clearance and payer reimbursement. 

• What’s the main benefit of having an IEP?

   It cuts approval‑to‑coverage lag by ≈ 12 months and avoids duplicate studies by designing multi‑purpose protocols—often saving up to 30 % in study costs while accelerating revenue and patient access. 

• When is the best time to start an IEP?

   Earlier is ideal (concept or feasibility), but it’s never “too late.” Even mid‑development, an IEP can realign ongoing trials, prioritize the remaining evidence gaps, and prevent costly post‑market surprises. 

• What do receive from an IEP engagement?

  • A living Excel + PPT roadmap covering 3–5 years of studies, timelines, and budgets.
  • An Evidence‑Impact Scorecard that ranks each study’s ROI.
  • A claims matrix mapping data to regulatory, clinical, and payer requirements.
  • A dashboard to track milestones, spend, and ROI as data accrue.